Skip to main content

Table 4 Number of bleeding cases by dose of dabigatran

From: Retrospective cohort study of the efficacy and safety of dabigatran: real-life dabigatran use including very low-dose 75 mg twice daily administration

Classification of bleeding

Total (n = 701)

150 mg and 110 mg twice daily (n = 675)

75 mg twice daily (n = 26)

P-value

Major bleeding

11 (1.6%)

11 (1.6%)

0 (0.0%)

1.000

Any bleeding

57 (8.1%)

54 (8.0%)

3 (11.5%)

0.461